Whitehawk Therapeutics, Inc. Common Stock (WHWK) is a publicly traded Healthcare sector company. As of July 7, 2026, WHWK trades at $3.86 with a market cap of $207.21M and a P/E ratio of -12.35. WHWK moved -4.98% today. Year to date, WHWK is +62.75%; over the trailing twelve months it is +102.01%. Its 52-week range spans $1.39 to $5.50. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces WHWK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks WHWK insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.86 |
| Market Cap | $207.21M |
| P/E Ratio | -12.35 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.50 |
| 52-Week Low | $1.39 |
| Volume | 32.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.14M |
| Net Income | $-20.60M |
| Gross Margin | 89.36% |
6 analysts cover WHWK: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.